Compile Data Set for Download or QSAR
Report error Found 128 Enz. Inhib. hit(s) with all data for entry = 50000618
TargetC-C chemokine receptor type 9(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CCR9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-C chemokine receptor type 8(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CCR8 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-C chemokine receptor type 3(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CCR3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetChemerin-like receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CMKLR1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetCX3C chemokine receptor 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CX3CR1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 1(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CXCR1 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 6(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CXCR6 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 3(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CXCR3 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as induction of beta-arrest...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetAtypical chemokine receptor 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CCR10 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CCR2 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 4(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CXCR4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-C chemokine receptor type 5(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CCR5 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-C chemokine receptor type 6(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CCR6 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetAtypical chemokine receptor 3(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CXCR7 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-C chemokine receptor type 4(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CCR4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-C chemokine receptor type 7(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Antagonist activity at CCR7 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 5(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataEC50: >1.00E+4nMAssay Description:Agonist activity at CXCR5 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255551(CHEMBL4066904)
Affinity DataIC50: 0.158nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255543(CHEMBL4082136)
Affinity DataIC50: 0.200nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255536(CHEMBL4098864)
Affinity DataIC50: 0.200nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255490(CHEMBL4060139)
Affinity DataIC50: 0.251nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255548(CHEMBL4072270)
Affinity DataIC50: 0.251nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255564(CHEMBL4062361)
Affinity DataIC50: 0.251nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255537(CHEMBL4077201)
Affinity DataIC50: 0.316nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255482(CHEMBL4086957)
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255503(CHEMBL4066818)
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50182263(CHEMBL3817901)
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255553(CHEMBL4070506)
Affinity DataIC50: 0.398nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255478(CHEMBL4082031)
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255484(CHEMBL4103349)
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255540(CHEMBL4066510)
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255541(CHEMBL4088551)
Affinity DataIC50: 0.501nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255481(CHEMBL4098979)
Affinity DataIC50: 0.631nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255485(CHEMBL4079102)
Affinity DataIC50: 0.631nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255562(CHEMBL4089421)
Affinity DataIC50: 0.794nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255497(CHEMBL4094324)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255479(CHEMBL4067429)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255547(CHEMBL4076053)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255480(CHEMBL4100674)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255539(CHEMBL4095602)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255545(CHEMBL4097602)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255544(CHEMBL4076428)
Affinity DataIC50: 1nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255459(CHEMBL4084077)
Affinity DataIC50: 1.30nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255523(CHEMBL4062546)
Affinity DataIC50: 1.30nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255550(CHEMBL4076478)
Affinity DataIC50: 1.30nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255535(CHEMBL4079718)
Affinity DataIC50: 1.30nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255542(CHEMBL4084135)
Affinity DataIC50: 1.60nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
TargetC-X-C chemokine receptor type 2(Human)
Gsk Pharmaceuticals R & D

Curated by ChEMBL
LigandPNGBDBM50255495(CHEMBL4098536)
Affinity DataIC50: 1.60nMAssay Description:Antagonist activity at TEV protease cleavage site linked GAL4-VP16-fused recombinant human CXCR2 expressed in cells assessed as inhibition of TEV pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/14/2019
Entry Details Article
PubMed
Displayed 1 to 50 (of 128 total ) | Next | Last >>
Jump to: